(Q38127505)

29 August 2017

0 references

Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis (English)

1 reference

29 August 2017

1 reference

1 reference

Jigang Yang

1

1 reference

29 August 2017

Ying Kan

2

1 reference

29 August 2017

Benjamin H Ge

3

1 reference

29 August 2017

Leilei Yuan

4

1 reference

29 August 2017

Chunlin Li

5

1 reference

29 August 2017

Wenrui Zhao

6

1 reference

29 August 2017

language of work or name

English

0 references

publication date

8 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

55

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

389-398

1 reference

Classification and nomenclature of somatostatin receptors

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Diagnostic role of 18F-dihydroxyphenylalanine positron emission tomography in patients with congenital hyperinsulinism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Meta-DiSc: a software for meta-analysis of test accuracy data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Review of functional/anatomical imaging in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Detection of metastases from gastrointestinal neuroendocrine tumors: prospective comparison of 18F-TOCA PET, triple-phase CT, and PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0284185113496679

21 January 2018

Identifiers

DOI

10.1177/0284185113496679

1 reference

29 August 2017

1 reference